Washington Healthcare Update - August 2021 #3 | McGuireWoods Consulting jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Major Shift in Demand For Oxygen Therapy Devices – New Study For 2021
By John Fraser and Kamran Zamanian, Ph.D., iData Research
The continual administration of medical oxygen, known as oxygen therapy, is used to treat a variety of medical conditions, such as cancer, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Generally, oxygen therapy devices are used to treat patients who can no longer receive adequate volumes of oxygen through regular breathing and those who require higher concentrations of oxygen. The long-term driver of sales for these devices is the movement away from traditional cylinder-based methods of oxygen delivery and toward portable concentrating technology.
Protech Home Medical Reports Strong Fourth Quarter and Record Audited Full Year Fiscal 2020 Financial Results Posts Q4 Revenue Growth of 28% and Adjusted EBITDA Growth of 69%
February 01, 2021 08:41 ET | Source: Protech Home Medical Corp. Protech Home Medical Corp. Wilder, Kentucky, UNITED STATES
Protech” or the “
Company”) (TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced its fourth quarter and audited full year fiscal 2020 financial results and operational highlights for the period ended September 30, 2020. After a delay in receiving the auditors opinion, the financial statements of the Company for fiscal years ended September 30, 2020 and 2019 and accompanying Management Discussion & Analysis (MD&A) have now been filed and are now available at www.sedar.com.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Protech Home Medical Reports Strong Fourth Quarter and Record Audited Full Year Fiscal 2020 .
Protech Home Medical Corp.February 1, 2021 GMT
CINCINNATI, Ohio, Feb. 01, 2021 (GLOBE NEWSWIRE) Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced its fourth quarter and audited full year fiscal 2020 financial results and operational highlights for the period ended September 30, 2020. After a delay in receiving the auditors opinion, the financial statements of the Company for fiscal years ended September 30, 2020 and 2019 and accompanying Management Discussion & Analysis (MD&A) have now been filed and are now available at www.sedar.com.
Orthotics (leg, arm, back, and neck braces).
Enteral/parenteral nutrition.
DME (and related accessories and supplies other than drugs), such as oxygen and oxygen equipment, wheelchairs, infusion pumps, and nebulizers.
4
Vision items and services, such as prosthetic lenses.
Other items and services that are statutorily excluded from Medicare coverage for which CMS or other government or private insurers have identified a claims processing need for a HCPCS Level II code, such as hearing aids.
These HCPCS processes would not apply to items and services described in the oral health and dentistry codes that begin with the letter “D” (CDT codes), nor would then apply to items and services coded internally by CMS and that are not based on an external coding application.